English
Insider transactions
EDGARSepterna, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 43 transactions, 1,923,134 shares
- Sum of shares × price per share: 81,715,048.1073
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 104
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 Filed 2026-11-18 | Labrucherie Gil M Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 15,815 | 41.4754 | 655,933.451Derived: shares × price per share. Exact value 655933.4510. | 24,185 | Indirect (I) By Trust | Yes | F1, F2, F3
| Open filing 0001193125-26-467395 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-18 | Labrucherie Gil M Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,485 | 41.9873 | 146,325.7405Derived: shares × price per share. Exact value 146325.7405. | 20,700 | Indirect (I) By Trust | Yes | F1, F4, F3
| Open filing 0001193125-26-467395 Read from the filing’s XML Dispute this row |
| 2026-11-16 Filed 2026-11-18 | Labrucherie Gil M Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 700 | 43 | 30,100Derived: shares × price per share. Exact value 30100. | 20,000 | Indirect (I) By Trust | Yes | F1, F3
| Open filing 0001193125-26-467395 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-16 | Finer Jeffrey Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 18,500 | 2.76 | 51,060Derived: shares × price per share. Exact value 51060.00. | 852,409 | Direct (D) | Yes | F1
| Open filing 0001193125-26-464072 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-16 | Finer Jeffrey Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,600 | 42.0888 | 235,697.28Derived: shares × price per share. Exact value 235697.2800. | 846,809 | Direct (D) | Yes | F2, F3
| Open filing 0001193125-26-464072 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-16 | Finer Jeffrey Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,300 | 43.0959 | 228,408.27Derived: shares × price per share. Exact value 228408.2700. | 841,509 | Direct (D) | Yes | F2, F4
| Open filing 0001193125-26-464072 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-16 | Finer Jeffrey Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,800 | 44.2261 | 123,833.08Derived: shares × price per share. Exact value 123833.0800. | 838,709 | Direct (D) | Yes | F2, F5
| Open filing 0001193125-26-464072 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-16 | Finer Jeffrey Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,823 | 45.2751 | 127,811.6073Derived: shares × price per share. Exact value 127811.6073. | 835,886 | Direct (D) | Yes | F2, F6
| Open filing 0001193125-26-464072 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-16 | Finer Jeffrey Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,977 | 46.1631 | 91,264.4487Derived: shares × price per share. Exact value 91264.4487. | 833,909 | Direct (D) | Yes | F2, F7
| Open filing 0001193125-26-464072 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-16 | Finer Jeffrey Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 18,500 | 0 | — | 378,712 | Direct (D) | Yes | F8
| Open filing 0001193125-26-464072 Read from the filing’s XML Dispute this row |
| 2026-11-11 Filed 2026-11-13 | Ezekowitz Alan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,939 | 46.005 | 319,228.695Derived: shares × price per share. Exact value 319228.695. | 110,481 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-461248 Read from the filing’s XML Dispute this row |
| 2026-11-11 Filed 2026-11-13 | Ezekowitz Alan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 13,201 | 47.0116 | 620,600.1316Derived: shares × price per share. Exact value 620600.1316. | 97,280 | Direct (D) | Yes | F1, F3
| Open filing 0001193125-26-461248 Read from the filing’s XML Dispute this row |
| 2026-11-11 Filed 2026-11-13 | Ezekowitz Alan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 22,865 | 47.7799 | 1,092,487.4135Derived: shares × price per share. Exact value 1092487.4135. | 74,415 | Direct (D) | Yes | F1, F4
| Open filing 0001193125-26-461248 Read from the filing’s XML Dispute this row |
| 2026-11-11 Filed 2026-11-13 | Ezekowitz Alan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 31,572 | 48.7002 | 1,537,562.7144Derived: shares × price per share. Exact value 1537562.7144. | 42,843 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-461248 Read from the filing’s XML Dispute this row |
| 2026-11-11 Filed 2026-11-13 | Ezekowitz Alan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,175 | 49.6465 | 207,274.1375Derived: shares × price per share. Exact value 207274.1375. | 38,668 | Direct (D) | Yes | F1, F6
| Open filing 0001193125-26-461248 Read from the filing’s XML Dispute this row |
| 2026-11-11 Filed 2026-11-13 | Ezekowitz Alan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,013 | 50.897 | 102,455.661Derived: shares × price per share. Exact value 102455.661. | 36,655 | Direct (D) | Yes | F1, F7
| Open filing 0001193125-26-461248 Read from the filing’s XML Dispute this row |
| 2026-11-11 Filed 2026-11-13 | Ezekowitz Alan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,055 | 51.9 | 54,754.5Derived: shares × price per share. Exact value 54754.5. | 35,600 | Direct (D) | Yes | F1
| Open filing 0001193125-26-461248 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-19 | Bhatt Elizabeth Officer: President and COO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 4,000 | 6.81 | 27,240Derived: shares × price per share. Exact value 27240.00. | 178,209 | Direct (D) | Yes | — | Open filing 0001193125-26-425485 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-19 | Bhatt Elizabeth Officer: President and COO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,094 | 36.8715 | 40,337.421Derived: shares × price per share. Exact value 40337.4210. | 177,115 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-425485 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-19 | Bhatt Elizabeth Officer: President and COO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,906 | 37.6142 | 109,306.8652Derived: shares × price per share. Exact value 109306.8652. | 174,209 | Direct (D) | Yes | F1, F3
| Open filing 0001193125-26-425485 Read from the filing’s XML Dispute this row |
| 2026-10-15 Filed 2026-10-19 | Bhatt Elizabeth Officer: President and COO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 4,000 | 0 | — | 58,230 | Direct (D) | Yes | F4
| Open filing 0001193125-26-425485 Read from the filing’s XML Dispute this row |
| 2026-09-08 Filed 2026-09-10 | Patni Rajiv Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 275,000 | 0 | — | 275,000 | Direct (D) | No | F1
| Open filing 0001193125-26-388033 Read from the filing’s XML Dispute this row |
| 2026-09-01 Filed 2026-09-03 | Long Daniel D. Officer: SVP, Drug Discovery | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,333 | 2.76 | 9,199.08Derived: shares × price per share. Exact value 9199.08. | 99,745 | Direct (D) | Yes | — | Open filing 0001193125-26-382267 Read from the filing’s XML Dispute this row |
| 2026-09-01 Filed 2026-09-03 | Long Daniel D. Officer: SVP, Drug Discovery | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,333 | 37.8271 | 126,077.7243Derived: shares × price per share. Exact value 126077.7243. | 96,412 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-382267 Read from the filing’s XML Dispute this row |
| 2026-09-01 Filed 2026-09-03 | Long Daniel D. Officer: SVP, Drug Discovery | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,333 | 0 | — | 9,085 | Direct (D) | Yes | F3
| Open filing 0001193125-26-382267 Read from the filing’s XML Dispute this row |
| 2026-08-12 Filed 2026-08-14 | Third Rock Ventures V, L.P. 10% ownerThird Rock Ventures GP V, LP 10% ownerTRV GP V, LLC 10% ownerThird Rock Ventures VI, L.P. 10% ownerThird Rock Ventures GP VI, L.P. 10% ownerTRV GP VI, LLC 10% owner | SOpen market or private sale of non-derivative or derivative security | Acquired (A) | 147,059 | 50.27 | 7,392,655.93Derived: shares × price per share. Exact value 7392655.93. | 6,068,532 | Direct (D) | Yes | F1, F2, F3
| Open filing 0001193125-26-352692 Read from the filing’s XML Dispute this row |
| 2026-08-12 Filed 2026-08-14 | Third Rock Ventures V, L.P. 10% ownerThird Rock Ventures GP V, LP 10% ownerTRV GP V, LLC 10% ownerThird Rock Ventures VI, L.P. 10% ownerThird Rock Ventures GP VI, L.P. 10% ownerTRV GP VI, LLC 10% owner | SOpen market or private sale of non-derivative or derivative security | Acquired (A) | 141 | 51.08 | 7,202.28Derived: shares × price per share. Exact value 7202.28. | 6,068,391 | Direct (D) | Yes | F1, F4, F3
| Open filing 0001193125-26-352692 Read from the filing’s XML Dispute this row |
| 2026-08-12 Filed 2026-08-14 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund III, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 746,500 | 42.50 | 31,726,250Derived: shares × price per share. Exact value 31726250.00. | 4,777,415 | Indirect (I) See footnotes | No | F1, F2
| Open filing 0001231919-26-000938 Read from the filing’s XML Dispute this row |
| 2026-08-12 Filed 2026-08-14 | RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund III, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 746,500 | 42.50 | 31,726,250Derived: shares × price per share. Exact value 31726250.00. | 725,443 | Indirect (I) See footnotes | No | F1, F3
| Open filing 0001231919-26-000938 Read from the filing’s XML Dispute this row |
| 2026-08-11 Filed 2026-08-13 | Bhatt Elizabeth Officer: President and COO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 18,681 | 6.81 | 127,217.61Derived: shares × price per share. Exact value 127217.61. | 192,890 | Direct (D) | Yes | — | Open filing 0001193125-26-349810 Read from the filing’s XML Dispute this row |
| 2026-08-11 Filed 2026-08-13 | Bhatt Elizabeth Officer: President and COO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 6,319 | 2.76 | 17,440.44Derived: shares × price per share. Exact value 17440.44. | 199,209 | Direct (D) | Yes | — | Open filing 0001193125-26-349810 Read from the filing’s XML Dispute this row |
| 2026-08-11 Filed 2026-08-13 | Bhatt Elizabeth Officer: President and COO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 25,000 | 44 | 1,100,000Derived: shares × price per share. Exact value 1100000. | 174,209 | Direct (D) | Yes | F1
| Open filing 0001193125-26-349810 Read from the filing’s XML Dispute this row |
| 2026-08-11 Filed 2026-08-13 | Bhatt Elizabeth Officer: President and COO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 18,681 | 0 | — | 62,230 | Direct (D) | Yes | F2
| Open filing 0001193125-26-349810 Read from the filing’s XML Dispute this row |
| 2026-08-11 Filed 2026-08-13 | Bhatt Elizabeth Officer: President and COO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 6,319 | 0 | — | 82,332 | Direct (D) | Yes | F3
| Open filing 0001193125-26-349810 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Long Daniel D. Officer: SVP, Drug Discovery | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 1,816 | 2.76 | 5,012.16Derived: shares × price per share. Exact value 5012.16. | 98,228 | Direct (D) | Yes | — | Open filing 0001193125-26-335820 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Long Daniel D. Officer: SVP, Drug Discovery | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 1,518 | 2.76 | 4,189.68Derived: shares × price per share. Exact value 4189.68. | 99,746 | Direct (D) | Yes | — | Open filing 0001193125-26-335820 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Long Daniel D. Officer: SVP, Drug Discovery | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,000 | 33.9756 | 33,975.6Derived: shares × price per share. Exact value 33975.6000. | 98,746 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-335820 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Long Daniel D. Officer: SVP, Drug Discovery | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,334 | 34.6805 | 80,944.287Derived: shares × price per share. Exact value 80944.2870. | 96,412 | Direct (D) | Yes | F1, F3
| Open filing 0001193125-26-335820 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Long Daniel D. Officer: SVP, Drug Discovery | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 1,816 | 0 | — | 5,227 | Direct (D) | Yes | F4
| Open filing 0001193125-26-335820 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Long Daniel D. Officer: SVP, Drug Discovery | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 1,518 | 0 | — | 12,418 | Direct (D) | Yes | F5
| Open filing 0001193125-26-335820 Read from the filing’s XML Dispute this row |
| 2026-07-15 Filed 2026-07-17 | Bhatt Elizabeth Officer: President and COO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 4,000 | 6.81 | 27,240Derived: shares × price per share. Exact value 27240.00. | 178,209 | Direct (D) | Yes | — | Open filing 0001193125-26-308073 Read from the filing’s XML Dispute this row |
| 2026-07-15 Filed 2026-07-17 | Bhatt Elizabeth Officer: President and COO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,000 | 33.9935 | 135,974Derived: shares × price per share. Exact value 135974.0000. | 174,209 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-308073 Read from the filing’s XML Dispute this row |
| 2026-07-15 Filed 2026-07-17 | Bhatt Elizabeth Officer: President and COO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 4,000 | 0 | — | 80,911 | Direct (D) | Yes | F3
| Open filing 0001193125-26-308073 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Long Daniel D. Officer: SVP, Drug Discovery | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,333 | 2.76 | 9,199.08Derived: shares × price per share. Exact value 9199.08. | 99,745 | Direct (D) | Yes | — | Open filing 0001193125-26-295106 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Long Daniel D. Officer: SVP, Drug Discovery | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,100 | 34.0964 | 71,602.44Derived: shares × price per share. Exact value 71602.4400. | 97,645 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-295106 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Long Daniel D. Officer: SVP, Drug Discovery | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,233 | 34.8141 | 42,925.7853Derived: shares × price per share. Exact value 42925.7853. | 96,412 | Direct (D) | Yes | F1, F3
| Open filing 0001193125-26-295106 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Long Daniel D. Officer: SVP, Drug Discovery | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,333 | 0 | — | 7,043 | Direct (D) | Yes | F4
| Open filing 0001193125-26-295106 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-06-30 | Shaikhly Samira Officer: Chief People Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 2,178 | 6.81 | 14,832.18Derived: shares × price per share. Exact value 14832.18. | 2,971 | Direct (D) | Yes | — | Open filing 0001193125-26-291059 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-06-30 | Shaikhly Samira Officer: Chief People Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,178 | 35.18 | 76,622.04Derived: shares × price per share. Exact value 76622.04. | 793 | Direct (D) | Yes | F1
| Open filing 0001193125-26-291059 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-06-30 | Shaikhly Samira Officer: Chief People Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 2,178 | 0 | — | 20,865 | Direct (D) | Yes | F2
| Open filing 0001193125-26-291059 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,176 filings read.
Showing 1–50 of 179
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| TRV GP V, LLC | 6,068,391 SH | 237,456,140 dollars | Lower by 147,200 Prior quarter: 6,215,591 | Open filing 0001193125-26-463550 Filed 2026-11-16 Dispute this row |
| RA CAPITAL MANAGEMENT, L.P. | 5,502,858 SH | 215,326,834 dollars | Lower by 1,493,000 Prior quarter: 6,995,858 | Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row |
| Driehaus Capital Management LLC | 4,273,431 SH | 167,219,355 dollars | Lower by 159,627 Prior quarter: 4,433,058 | Open filing 0000938206-26-000066 Filed 2026-11-16 Dispute this row |
| TRV GP VI, LLC | 4,211,659 SH | 164,802,217 dollars | Unchanged Prior quarter: 4,211,659 | Open filing 0001193125-26-463547 Filed 2026-11-16 Dispute this row |
| SAMSARA BIOCAPITAL, LLC | 3,066,453 SH | 119,990,306 dollars | Lower by 82,675 Prior quarter: 3,149,128 | Open filing 0001744967-26-000014 Filed 2026-11-16 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 3,018,431 SH | 118,111,215 dollars | Lower by 44,335 Prior quarter: 3,062,766 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 2,074,603 SH | 81,179,215 dollars | Higher by 142,515 Prior quarter: 1,932,088 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Siren, L.L.C. Partly reported under another manager | 1,700,000 SH | 66,521,000 dollars | Lower by 200,000 Prior quarter: 1,900,000 | Open filing 0002005245-26-000013 Filed 2026-11-12 Dispute this row |
| Janus Henderson Group Ltd. Partly reported under another manager | 1,611,125 SH | 63,091,655 dollars | Not in the prior quarter’s filings read | Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,354,288 SH | 52,993,289 dollars | Higher by 132,615 Prior quarter: 1,221,673 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| PRIMECAP MANAGEMENT CO/CA/ | 1,354,261 SH | 52,992,233 dollars | Higher by 186,879 Prior quarter: 1,167,382 | Open filing 0000763212-26-000037 Filed 2026-11-12 Dispute this row |
| Avoro Capital Advisors LLC | 1,300,000 SH | 50,869,000 dollars | Lower by 37,500 Prior quarter: 1,337,500 | Open filing 0001104659-26-127608 Filed 2026-11-16 Dispute this row |
| First Light Asset Management, LLC | 1,164,271 SH | 45,557,924 dollars | Higher by 201,011 Prior quarter: 963,260 | Open filing 0001999371-26-025524 Filed 2026-11-16 Dispute this row |
| ADAR1 Capital Management, LLC | 974,396 SH | 38,128,115 dollars | Higher by 33,649 Prior quarter: 940,747 | Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row |
| FMR LLC Partly reported under another manager | 865,636 SH | 33,872,337 dollars | Higher by 842,396 Prior quarter: 23,240 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 798,146 SH | 31,231,453 dollars | Higher by 145,516 Prior quarter: 652,630 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 686,792 SH | 26,879,965 dollars | Higher by 7,629 Prior quarter: 679,163 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| LOOMIS SAYLES CO L P Partly reported under another manager | 646,663 SH | 25,303,923 dollars | Higher by 21,911 Prior quarter: 624,752 | Open filing 0000312348-26-000039 Filed 2026-11-12 Dispute this row |
| PERCEPTIVE ADVISORS LLC | 567,479 SH | 22,205,453 dollars | Not in the prior quarter’s filings read | Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row |
| Casdin Capital, LLC | 553,268 SH | 21,649,377 dollars | Unchanged Prior quarter: 553,268 | Open filing 0000919574-26-008113 Filed 2026-11-16 Dispute this row |
| Catalio Capital Management, LP | 454,015 SH | 17,765,607 dollars | Lower by 82,137 Prior quarter: 536,152 | Open filing 0001958125-26-000012 Filed 2026-11-16 Dispute this row |
| ALGERT GLOBAL LLC Partly reported under another manager | 451,116 SH | 17,652,169 dollars | Higher by 53,629 Prior quarter: 397,487 | Open filing 0001275218-26-000018 Filed 2026-11-17 Dispute this row |
| Soleus Capital Management, L.P. | 330,000 SH | 12,912,900 dollars | Higher by 55,000 Prior quarter: 275,000 | Open filing 0001802630-26-000008 Filed 2026-11-16 Dispute this row |
| BRAIDWELL LP | 328,240 SH | 12,844,031 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row |
| Balyasny Asset Management L.P. | 323,271 SH | 12,649,594 dollars | Lower by 27,171 Prior quarter: 350,442 | Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 253,253 SH | 9,909,790 dollars | Higher by 23,069 Prior quarter: 230,184 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| D. E. Shaw Co., Inc. Partly reported under another manager | 233,199 SH | 9,125,077 dollars | Higher by 186,716 Prior quarter: 46,483 | Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row |
| Universal- Beteiligungs- und Servicegesellschaft mbH Partly reported under another manager | 223,576 SH | 8,748,529 dollars | Higher by 874 Prior quarter: 222,702 | Open filing 0002057170-26-000022 Filed 2026-11-10 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 209,685 SH | 8,204,974 dollars | Higher by 161,456 Prior quarter: 48,229 | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 208,899 SH | 8,174,218 dollars | Higher by 21,858 Prior quarter: 187,041 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 207,006 SH | 8,100,146 dollars | Higher by 72,629 Prior quarter: 134,377 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 202,170 SH | 7,910,912 dollars | Higher by 1,039 Prior quarter: 201,131 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 199,000 SH | 7,786,870 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| Kalehua Capital Management LLC | 194,544 SH | 7,612,507 dollars | Lower by 194,544 Prior quarter: 389,088 | Open filing 0002106181-26-000010 Filed 2026-11-13 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 171,681 SH | 6,717,878 dollars | Higher by 6,025 Prior quarter: 165,656 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| Qube Research Technologies Ltd | 162,879 SH | 6,373,455 dollars | Not in the prior quarter’s filings read | Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row |
| UBS Group AG Partly reported under another manager | 157,186 SH | 6,150,688 dollars | Higher by 67,312 Prior quarter: 89,874 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| AMERIPRISE FINANCIAL INC Partly reported under another manager | 152,156 SH | 5,953,863 dollars | Not in the prior quarter’s filings read | Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row |
| Longaeva Partners L.P. Partly reported under another manager | 142,259 SH | 5,566,595 dollars | Lower by 155,912 Prior quarter: 298,171 | Open filing 0001193125-26-463222 Filed 2026-11-16 Dispute this row |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Partly reported under another manager | 131,731 SH | 5,154,634 dollars | Higher by 57,082 Prior quarter: 74,649 | Open filing 0001164508-26-000060 Filed 2026-11-13 Dispute this row |
| Ikarian Capital, LLC Option: Call | 127,200 SH | 4,977,336 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row |
| TWO SIGMA INVESTMENTS, LP | 112,749 SH | 4,411,868 dollars | Lower by 108,136 Prior quarter: 220,885 | Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row |
| DIMENSIONAL FUND ADVISORS LP Partly reported under another manager | 107,373 SH | 4,201,505 dollars | Higher by 32,064 Prior quarter: 75,309 | Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row |
| NEUBERGER BERMAN GROUP LLC | 104,762 SH | 4,099,337 dollars | Not in the prior quarter’s filings read | Open filing 0001465109-26-000128 Filed 2026-11-13 Dispute this row |
| Ikarian Capital, LLC | 100,047 SH | 3,914,839 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row |
| Ikarian Capital, LLC Option: Put | 95,200 SH | 3,725,176 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 93,034 SH | 3,640,420 dollars | Higher by 38,545 Prior quarter: 54,489 | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| FEDERATED HERMES, INC. Partly reported under another manager | 92,413 SH | 3,616,121 dollars | Higher by 5,660 Prior quarter: 86,753 | Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 85,489 SH | 3,345,185 dollars | Higher by 188 Prior quarter: 85,301 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| AMERICAN CENTURY COMPANIES INC Partly reported under another manager | 79,358 SH | 3,105,279 dollars | Higher by 18,385 Prior quarter: 60,973 | Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Jupiter Topco LLC 1,307,500 SH
- Caption Management, LLC 440,000 SH
- Caption Management, LLC 200,000 SH
- TUDOR INVESTMENT CORP ET AL 200,000 SH
- Sixth Street Partners Management Company, L.P. 187,041 SH
- Woodline Partners LP 185,535 SH
- TUDOR INVESTMENT CORP ET AL 100,000 SH
- CITADEL ADVISORS LLC 81,800 SH
- DIADEMA PARTNERS LP 59,700 SH
- JANE STREET GROUP, LLC 57,200 SH
- JANE STREET GROUP, LLC 45,552 SH
- RENAISSANCE TECHNOLOGIES LLC 41,419 SH
- Caption Management, LLC 38,006 SH
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 33,900 SH
- TUDOR INVESTMENT CORP ET AL 28,966 SH
- Trexquant Investment LP 25,645 SH
- FOX RUN MANAGEMENT, L.L.C. 22,038 SH
- FRED ALGER MANAGEMENT, LLC 20,958 SH
- CIBC Bancorp USA Inc. 7,222 SH
- Rangeley Capital, LLC 7,200 SH
- SIMPLEX TRADING, LLC 2,500 SH
- BERTHEL, FISHER COMPANY FINANCIAL SERVICES, INC. 1,295 SH
- MERCER GLOBAL ADVISORS INC /ADV 630 SH
- Persistent Asset Partners Ltd 152 SH
- Caitong International Asset Management Co., Ltd 77 SH
- Integrated Wealth Concepts LLC 51 SH
- Ameritas Advisory Services, LLC 18 SH
- NATIONAL BANK OF CANADA /FI/ 7 SH
- Global Retirement Partners, LLC 3 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. Common Stock, $0.001 par value per share | 13.0 | 6,068,391 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-463540 Dispute this row |
| Third Rock Ventures GP V, L.P. Common Stock, $0.001 par value per share | 13.0 | 6,068,391 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-463540 Dispute this row |
| TRV GP V, LLC Common Stock, $0.001 par value per share | 13.0 | 6,068,391 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-463540 Dispute this row |
| Third Rock Ventures VI, L.P. Common Stock, $0.001 par value per share | 9.0 | 4,211,659 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-463540 Dispute this row |
| Third Rock Ventures GP VI, L.P. Common Stock, $0.001 par value per share | 9.0 | 4,211,659 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-463540 Dispute this row |
| TRV GP VI, LLC Common Stock, $0.001 par value per share | 9.0 | 4,211,659 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-463540 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.001 per share | 11.8 | 5,525,324.00 | 08/12/2026 Filed 2026-08-14 | SCHEDULE 13D/AAmendment 1 | Open filing 0001346824-26-000228 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.001 per share | 11.8 | 5,525,324.00 | 08/12/2026 Filed 2026-08-14 | SCHEDULE 13D/AAmendment 1 | Open filing 0001346824-26-000228 Dispute this row |
| Rajeev Shah Common Stock, par value $0.001 per share | 11.8 | 5,525,324.00 | 08/12/2026 Filed 2026-08-14 | SCHEDULE 13D/AAmendment 1 | Open filing 0001346824-26-000228 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, par value $0.001 per share | 10.2 | 4,777,415.00 | 08/12/2026 Filed 2026-08-14 | SCHEDULE 13D/AAmendment 1 | Open filing 0001346824-26-000228 Dispute this row |
| DRIEHAUS CAPITAL MANAGEMENT LLC Common Stock | 9.83 | 4,433,058 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0000938206-26-000037 Dispute this row |
| BIOTECHNOLOGY VALUE FUND L P Common Stock, $0.001 par value per share | 2.0 | 919,814.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-000473 Dispute this row |
| BVF I GP LLC Common Stock, $0.001 par value per share | 2.0 | 919,814.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-000473 Dispute this row |
| BIOTECHNOLOGY VALUE FUND II LP Common Stock, $0.001 par value per share | 1.5 | 671,492.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-000473 Dispute this row |
| BVF II GP LLC Common Stock, $0.001 par value per share | 1.5 | 671,492.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-000473 Dispute this row |
| Biotechnology Value Trading Fund OS LP Common Stock, $0.001 par value per share | 0.2 | 104,119.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-000473 Dispute this row |
| BVF Partners OS Ltd. Common Stock, $0.001 par value per share | 0.2 | 104,119.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-000473 Dispute this row |
| BVF GP HOLDINGS LLC Common Stock, $0.001 par value per share | 3.6 | 1,591,306.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-000473 Dispute this row |
| BVF PARTNERS L P/IL Common Stock, $0.001 par value per share | 3.8 | 1,720,782.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-000473 Dispute this row |
| BVF INC/IL Common Stock, $0.001 par value per share | 3.8 | 1,720,782.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-000473 Dispute this row |
| LAMPERT MARK N Common Stock, $0.001 par value per share | 3.8 | 1,720,782.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-000473 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,686,506 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 103,592 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,124 |
Filings made before the SEC required XML are listed, not extracted.